AVII Financial Facts

See Full Income Statement

Total Shareholders' Equity (Deficit): -175.89M
Cash and cash equivalents: -340.78M
See Full Balance Sheet

AVI Biopharma, Inc. (AVII) Earnings

  |   Expand Research on AVII
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +40.5% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -1.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/10/12 Q112 -$0.13-$0.07 -$0.06$11.2M$11.05M = Details
3/1/12 Q411 -$0.01-$0.06 +$0.05$13.6M$11.03M = Details
11/3/11 Q311 -$0.03-$0.06 +$0.03N/A$13.88M = Details
8/4/11 Q211 $0.01-$0.07 +$0.08$11.6M$13.67M = Details
5/5/11 Q111 $0.02-$0.03 +$0.05$15.3M$13.55M = Details
3/10/11 Q410 -$0.07-$0.07 $0.00$15.5M$11.65M = Details